Creatus Biosciences Inc. is a privately held biotechnology company developing industrially-scalable fermentation processes. The Company’s platform is a novel yeast which possesses a unique, mixed-sugar physiology, enabling multiple bio-product development from fermentable sugars.
The Company’s lead process is a fully-integrated biorefinery system for xylitol production from non-forestry, non-food biomass. The process disrupts current chemical production of xylitol with a low-cost, fermentation-based approach.
Company Details
- Employees
- 3
- Founded
- 2014
- Address
- 887 Great Northern Way, Vancouver,british Columbia V5t,canada
- Phone
- 1 604 691 2271
- in****@****bio.com
- Industry
- Biotechnology
- Website
- creatusbio.com
- HQ
- Vancouver, British Columbia
Creatus Biosciences Inc. Questions
Creatus Biosciences Inc.'s helpline number is 1 604 691 2271
Creatus Biosciences Inc.'s website is creatusbio.com
Creatus Biosciences Inc.'s LinkedIn profile is https://ca.linkedin.com/company/creatus-biosciences-inc-
Creatus Biosciences Inc. has
3 employees.
View email and phone details for 3
employees at Creatus Biosciences Inc..
Creatus Biosciences Inc.'s industry is
Biotechnology
Creatus Biosciences Inc.'s top competitors are
Melio Peptide Systems Inc.,
Cerecura Nanotherapeutics,
Reverb Therapeutics,
Dcx Biotherapeutics Corporation,
Augurex Life Sciences Corp.,
Amplitude Ventures,
Lux Bio,
Zymeworks Inc.,
Sitka Biopharma,
Qurcan Therapeutics Inc..
Creatus Biosciences Inc.'s support email address is info@creatusbio.com
Creatus Biosciences Inc.'s categories are Biotechnology
Creatus Biosciences Inc.'s founding year is 2014
